A Study of LY900014 in Participants With Type 1 Diabetes

NCT03214367 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1392

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 1 Diabetes Mellitus

Interventions

DRUG: LY900014
DRUG: Insulin Lispro
DRUG: Insulin Glargine
DRUG: Insulin Degludec

Sponsor

Eli Lilly and Company